BRAINCOOL AB Cash Flow Conversion Efficiency
BRAINCOOL AB cash flow conversion efficiency. Based on the latest financial reports, BRAINCOOL AB (5YL) has a cash flow conversion efficiency ratio of -0.095x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-15.85 Million ≈ $-18.53 Million USD) by net assets (€167.46 Million ≈ $195.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of BRAINCOOL AB (2021–2025)
Cash flow conversion efficiency of BRAINCOOL AB from 2021 to 2025. This chart illustrates how BRAINCOOL AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 5YL share price today for real-time trading data and today's change.
BRAINCOOL AB Cash Flow Conversion Ratio Explained
BRAINCOOL AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
BRAINCOOL AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BRAINCOOL AB ranked by their cash flow conversion efficiency. Also see 5YL market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bintang Mitra Semestaraya Tbk
JK:BMSR
|
0.027x |
|
BIT Mining Limited
NYSE:BTCM
|
-0.167x |
|
Is Yatirim Ortakligi AS
IS:ISYAT
|
0.069x |
|
Pantheon International PLC
LSE:PIN
|
-0.007x |
|
Aurania Resources Ltd
V:ARU
|
0.119x |
|
Muar Ban Lee Group Bhd
KLSE:5152
|
0.017x |
|
Ecolomondo Corp
V:ECM
|
3.144x |
|
Studio Mir Co. Ltd.
KQ:408900
|
-0.036x |
Annual Cash Flow Conversion Efficiency for BRAINCOOL AB (2021–2025)
The table below shows the annual cash flow conversion efficiency of BRAINCOOL AB from 2021 to 2025. Review BRAINCOOL AB leverage flexibility ratio to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €175.80 Million ≈ $205.53 Million |
€-52.68 Million ≈ $-61.58 Million |
-0.300x | +30.19% |
| 2024-12-31 | €145.93 Million ≈ $170.61 Million |
€-62.64 Million ≈ $-73.23 Million |
-0.429x | +21.58% |
| 2023-12-31 | €111.74 Million ≈ $130.63 Million |
€-61.16 Million ≈ $-71.50 Million |
-0.547x | -37.50% |
| 2022-12-31 | €116.23 Million ≈ $135.89 Million |
€-46.27 Million ≈ $-54.09 Million |
-0.398x | +25.74% |
| 2021-12-31 | €45.23 Million ≈ $52.88 Million |
€-24.25 Million ≈ $-28.35 Million |
-0.536x | -- |
About BRAINCOOL AB
BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powe… Read more